
Sign up to save your podcasts
Or


Listen to our guest, Dr. Suneil Hosmane (Executive Vice President and Global Head of Diagnostics at GENFIT), as he speaks about the role of AI digital pathology, the latest NIS4 blood-based diagnostic test by Genfit and how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts in NASH clinical trials today that could ultimately transform the NASH clinical care pathway.
Episode 3 of Dialogues on AI Digital Pathology is coming up soon! Here's a sound bite from our guest, Dr. Suneil Hosmane, Executive Vice President and Global Head of Diagnostics at GENFIT, who will share his views on how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts and benefit patient outcomes. Watch out for our updates next week when Episode 3 goes Live!
In Episode 2 of Dialogues on Digital Pathology, we speak to Dr. David Kleiner, Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, from the Center for Cancer Research at the National Cancer Institute.
Dr. Kleiner will be sharing his views on AI digital pathology and how it can work hand-in-hand with liver pathologists to empower NASH drug development and clinical practice. During the Q&A segment, Dr. Kleiner will be joined by supporting guest, Dr. Dean Tai, Chief Scientific Officer of HistoIndex, who will provide his insights on the role of machine learning in reinforcing important diagnostic decisions for NASH.
Watch out for our upcoming episode next week with our guest, Dr. David Kleiner, Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, from the Center for Cancer Research at the National Cancer Institute. Dr. Kleiner will be sharing his views on AI digital pathology and how it can work hand-in-hand with liver pathologists to empower NASH drug development and clinical practice.
The full episode will be launched in a few days, and will include a Q&A segment with supporting guest, Dr. Dean Tai, Chief Scientific Officer of HistoIndex. Enjoy the trailer!
Featured Music by Kevin MacLeod; Cover Art Image by Matt Botsford on Unsplash
In our inaugural episode, we speak to Dr. Stephen Harrison (Medical Director of Pinnacle Clinical Research) on the role AI digital pathology can play in current NASH drug development.
Welcome to Dialogues on AI Digital Pathology, a podcast/webinar series where medical and industry experts will be sharing their views on the evolving trends of AI digital pathology and its role in finding effective treatments for Nonalcoholic Steatohepatitis (NASH). We look forward to bringing you more insights on AI digital pathology in every episode, so do stay tuned!
Featured Music by Kevin MacLeod
Cover Art Image by Matt Botsford on Unsplash
From the publisher's feed